-
1 Comment
From a valuation standpoint, the stock is 97.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 39.0.
Based on the above factors, INVO Bioscience, Inc gets an overall score of 1/5.
Exchange | NASDAQ |
---|---|
CurrencyCode | USD |
ISIN | US44984F3029 |
Sector | Healthcare |
Industry | Medical Devices |
Market Cap | 3M |
---|---|
Beta | 1.44 |
PE Ratio | 1.21 |
Target Price | 20 |
Dividend Yield | None |
INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for INVO using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025